IRIS Accounts Production v25.1.0.734 12489336 Board of Directors 1.1.24 31.12.24 31.12.24 0 0 false true false false true false Ordinary 0.01000 B Ordinary 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh124893362023-12-31124893362024-12-31124893362024-01-012024-12-31124893362022-12-31124893362023-01-012023-12-31124893362023-12-3112489336ns15:EnglandWales2024-01-012024-12-3112489336ns14:PoundSterling2024-01-012024-12-3112489336ns10:Director12024-01-012024-12-3112489336ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3112489336ns10:SmallEntities2024-01-012024-12-3112489336ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3112489336ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3112489336ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3112489336ns10:FullAccounts2024-01-012024-12-3112489336ns10:OrdinaryShareClass12024-01-012024-12-3112489336ns10:OrdinaryShareClass22024-01-012024-12-3112489336ns10:Director22024-01-012024-12-3112489336ns10:Director32024-01-012024-12-3112489336ns10:RegisteredOffice2024-01-012024-12-3112489336ns5:CurrentFinancialInstruments2024-12-3112489336ns5:CurrentFinancialInstruments2023-12-3112489336ns5:ShareCapital2024-12-3112489336ns5:ShareCapital2023-12-3112489336ns5:SharePremium2024-12-3112489336ns5:SharePremium2023-12-3112489336ns5:RetainedEarningsAccumulatedLosses2024-12-3112489336ns5:RetainedEarningsAccumulatedLosses2023-12-3112489336ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3112489336ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3112489336ns5:CurrentFinancialInstruments2024-01-012024-12-3112489336ns10:OrdinaryShareClass12024-12-3112489336ns10:OrdinaryShareClass22024-12-31
REGISTERED NUMBER: 12489336 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

ALTERNOX SCIENTIFIC LIMITED

ALTERNOX SCIENTIFIC LIMITED (REGISTERED NUMBER: 12489336)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


ALTERNOX SCIENTIFIC LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTORS: A S C Cooper
A L Moore
C Nicklin





REGISTERED OFFICE: Sussex Innovation Centre
Science Park Square
University of Sussex
BRIGHTON
East Sussex
BN1 9SB





REGISTERED NUMBER: 12489336 (England and Wales)





ACCOUNTANTS: Staffords
Chartered Accountants
Unit 1, Cambridge House
Camboro Business Park
Oakington Road, Girton
CAMBRIDGE
Cambridgeshire
CB3 0QH

ALTERNOX SCIENTIFIC LIMITED (REGISTERED NUMBER: 12489336)

BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £    £   
CURRENT ASSETS
Debtors 4 1,716 16
Cash at bank 35,112 66,242
36,828 66,258
CREDITORS
Amounts falling due within one year 5 172,571 168,757
NET CURRENT LIABILITIES (135,743 ) (102,499 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(135,743

)

(102,499

)

CAPITAL AND RESERVES
Called up share capital 6 10 10
Share premium 149,999 149,999
Retained earnings (285,752 ) (252,508 )
SHAREHOLDERS' FUNDS (135,743 ) (102,499 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 May 2025 and were signed on its behalf by:





A S C Cooper - Director


ALTERNOX SCIENTIFIC LIMITED (REGISTERED NUMBER: 12489336)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024


1. STATUTORY INFORMATION

Alternox Scientific Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 1,716 16

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 65,081 63,297
Other creditors 107,490 105,460
172,571 168,757

ALTERNOX SCIENTIFIC LIMITED (REGISTERED NUMBER: 12489336)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR - continued

Included within creditors is £54,960 is a loan owed to the University of Sussex, currently non interest bearing and repayable on the event of future funding.

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
880 Ordinary 1p 9 9
110 B Ordinary 1p 1 1
10 10

7. RELATED PARTY DISCLOSURES

Cooper Ventures Limited

A company of which ASC Cooper is a shareholder and director charged fees of £20,000 (2023: £NIL) to the company. At the year end, the balance owing to this related party was £NIL (which includes VAT where appropriate), with an amount of £2,000 being accrued for unbilled fees at the year end (2023: £NIL).